Acurx Pharmaceuticals (ACXP) Tops Q3 EPS by 3c

Acurx Pharmaceuticals (NASDAQ: ACXP) reported Q3 EPS of ($0.24), $0.03 better than the analyst estimate of ($0.27).

For earnings history and earnings-related data on Acurx Pharmaceuticals (ACXP) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Piper Sandler on Fervo Energy (FRVO): 'Capital Access Supports Potential Upside'
• Deutsche Bank Starts DexCom (DXCM) at Buy